March 26 (Reuters) - Intercept Pharmaceuticals Inc:
* INTERCEPT PHARMA - U.S. COURT GRANTED DEFENDANTS MOTION & DISMISSED WITH PREJUDICE DERIVATIVE LAWSUIT PURPORTEDLY BROUGHT ON BEHALF OF COMPANY
* INTERCEPT PHARMA SAYS LAWSUIT WAS FILED BY A STOCKHOLDER OF CO ON AUG 4, 2017 - SEC FILING Source text: (bit.ly/2DWMGnS) Further company coverage: